UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Increased Risk of Keratinocyte Carcinomas, Merkel Cell Carcinoma, and Other Skin Cancers in Patients Treated With Janus Kinase 1 and 2 Inhibitor, Ruxolitinib

Journal of cutaneous medicine and surgery, 2024-09, Vol.28 (5), p.486-487

2024

Volltextzugriff (PDF)

Psychological Distress and Treatment Outcome in Patients With Early-Stage Mycosis Fungoides

Journal of cutaneous medicine and surgery, 2024-01, Vol.28 (1), p.29-32

2024

Volltextzugriff (PDF)

Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development

Current oncology (Toronto), 2024-03, Vol.31 (3), p.1426-1444

2024

Volltextzugriff (PDF)

Primary Cutaneous Multifocal Indolent CD8+ T-Cell Lymphoma: A Novel Primary Cutaneous CD8+ T-Cell Lymphoma

Biomedicines, 2023-02, Vol.11 (2), p.634

2023

Volltextzugriff (PDF)

Tazarotene 0.1% Cream as Monotherapy for Early-Stage Cutaneous T-Cell Lymphoma

Journal of cutaneous medicine and surgery, 2016-05, Vol.20 (3), p.244-248

2016

Volltextzugriff (PDF)

A general practitioner's guide to hematopoietic stem-cell transplantation

Current oncology (Toronto), 2019-06, Vol.26 (3), p.187-191

2019

Volltextzugriff (PDF)

Cutaneous T-cell lymphoma developing in surgical scars post cardiac surgery: A case study

SAGE open medical case reports, 2023-01, Vol.11, p.2050313X231161444

2023

Volltextzugriff (PDF)

P376: VENO‐OCCLUSIVE DISEASE RISK AND OTHER OUTCOMES IN PATIENTS WITH B‐CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA RECEIVING INOTUZUMAB OZOGAMICIN AND PROCEEDING TO HEMATOPOIETIC STEM CELL TRANSPLANTATION

HemaSphere, 2023-08, Vol.7 (S3), p.e51811f0-n/a

2023

Volltextzugriff (PDF)

A REGISTRY-BASED, OBSERVATIONAL SAFETY STUDY OF INOTUZUMAB OZOGAMICIN (INO) IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PROCEEDING TO HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)

Hematology, Transfusion and Cell Therapy, 2021-11, Vol.43, p.S34-S34

2021

Volltextzugriff (PDF)

Allogeneic Hematopoietic Stem Cell Transplant Infusion During Venovenous Extracorporeal Membrane Oxygenation Support

Critical care explorations, 2021-10, Vol.3 (10), p.e551

2021

Volltextzugriff (PDF)

Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis – Authors' reply

The Lancet. Haematology, 2020-05, Vol.7 (5), p.e364-e365

2020

Volltextzugriff (PDF)

Analysis of acute myeloid leukemia incidence and geographic distribution in Canada from 1992 to 2010 reveals disease clusters in Sarnia and other industrial US border cities in Ontario

Cancer, 2019-06, Vol.125 (11), p.1886-1897

2019

Volltextzugriff (PDF)

Multiple myeloma epidemiology and patient geographic distribution in Canada: A population study

Cancer, 2019-07, Vol.125 (14), p.2435-2444

2019

Volltextzugriff (PDF)

Veno-Occlusive Disease Risk and Other Outcomes in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia Who Received Inotuzumab Ozogamicin and Proceeded to Hematopoietic Stem Cell Transplantation: A Registry-Based, Observational Study

Blood, 2022-11, Vol.140 (Supplement 1), p.6023-6025

2022

Volltextzugriff (PDF)

P244 False positive (self) antibodies in a haploidentical SCT case

Human immunology, 2017-09, Vol.78, p.234-234

2017

Volltextzugriff (PDF)

Identification of significant geographic clustering of polycythemia vera cases in Montreal, Canada

Cancer, 2019-11, Vol.125 (22), p.3953-3959

2019

Volltextzugriff (PDF)

A registry-based, observational safety study of inotuzumab ozogamicin (InO) treatment in patients (pts) with B-cell precursor acute lymphoblastic leukemia (ALL) who proceeded to hematopoietic stem cell transplant (HSCT)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.7017-7017

2021

Volltextzugriff (PDF)

Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease

The New England journal of medicine, 2024-09, Vol.391 (11), p.1002-1014

2024

Volltextzugriff (PDF)

POSTER: ALL-471 Veno-Occlusive Disease Risk and Other Outcomes in Patients With B-Cell Precursor Acute Lymphoblastic Leukemia Receiving Inotuzumab Ozogamicin and Proceeding to Hematopoietic Stem Cell Transplantation

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S152-S152

2023

Volltextzugriff (PDF)

ALL-471 Veno-Occlusive Disease Risk and Other Outcomes in Patients With B-Cell Precursor Acute Lymphoblastic Leukemia Receiving Inotuzumab Ozogamicin and Proceeding to Hematopoietic Stem Cell Transplantation

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S252-S252

2023

Volltextzugriff (PDF)

Somatic STAT3 Gain-of-Function (GOF) syndrome underlying susceptibility to Parvovirus B19, Pseudomonas aeruginosa, and Histoplasma capsulatum infections

Clinical infection in practice, 2024-11, Vol.24, p.100393, Article 100393

2024

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(40)
Berichte
(4)

Sprache

Englisch
(44)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Humans
(13)
Adult
(11)
Female
(10)
Male
(10)
Middle Aged
(10)
Aged
(9)
Oncology
(8)
Aged, 80 And Over
(6)
Young Adult
(6)
Hematology
(5)
Adolescent
(4)
Hematology, Oncology And Palliative Medicine
(4)
Incidence
(4)
Lymphoma
(4)
Risk Factors
(4)
Treatment Outcome
(4)
Cancer
(3)
Case Report
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial

Increased Risk of Keratinocyte Carcinomas, Merkel Cell Carcinoma, and Other Skin Cancers in Patients Treated With Janus Kinase 1 and 2 Inhibitor, Ruxolitinib

Psychological Distress and Treatment Outcome in Patients With Early-Stage Mycosis Fungoides

Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development

Primary Cutaneous Multifocal Indolent CD8+ T-Cell Lymphoma: A Novel Primary Cutaneous CD8+ T-Cell Lymphoma

Tazarotene 0.1% Cream as Monotherapy for Early-Stage Cutaneous T-Cell Lymphoma

A general practitioner's guide to hematopoietic stem-cell transplantation

Cutaneous T-cell lymphoma developing in surgical scars post cardiac surgery: A case study

P376: VENO‐OCCLUSIVE DISEASE RISK AND OTHER OUTCOMES IN PATIENTS WITH B‐CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA RECEIVING INOTUZUMAB OZOGAMICIN AND PROCEEDING TO HEMATOPOIETIC STEM CELL TRANSPLANTATION

A REGISTRY-BASED, OBSERVATIONAL SAFETY STUDY OF INOTUZUMAB OZOGAMICIN (INO) IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PROCEEDING TO HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)

Allogeneic Hematopoietic Stem Cell Transplant Infusion During Venovenous Extracorporeal Membrane Oxygenation Support

Thymoglobulin Decreases the Need for Immunosuppression at 12 Months after Myeloablative and Nonmyeloablative Unrelated Donor Transplantation: CBMTG 0801, a Randomized, Controlled Trial

Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis – Authors' reply

Analysis of acute myeloid leukemia incidence and geographic distribution in Canada from 1992 to 2010 reveals disease clusters in Sarnia and other industrial US border cities in Ontario

Multiple myeloma epidemiology and patient geographic distribution in Canada: A population study

Veno-Occlusive Disease Risk and Other Outcomes in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia Who Received Inotuzumab Ozogamicin and Proceeded to Hematopoietic Stem Cell Transplantation: A Registry-Based, Observational Study

P244 False positive (self) antibodies in a haploidentical SCT case

Identification of significant geographic clustering of polycythemia vera cases in Montreal, Canada

Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial

Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells

A registry-based, observational safety study of inotuzumab ozogamicin (InO) treatment in patients (pts) with B-cell precursor acute lymphoblastic leukemia (ALL) who proceeded to hematopoietic stem cell transplant (HSCT)

Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease

POSTER: ALL-471 Veno-Occlusive Disease Risk and Other Outcomes in Patients With B-Cell Precursor Acute Lymphoblastic Leukemia Receiving Inotuzumab Ozogamicin and Proceeding to Hematopoietic Stem Cell Transplantation

ALL-471 Veno-Occlusive Disease Risk and Other Outcomes in Patients With B-Cell Precursor Acute Lymphoblastic Leukemia Receiving Inotuzumab Ozogamicin and Proceeding to Hematopoietic Stem Cell Transplantation

Somatic STAT3 Gain-of-Function (GOF) syndrome underlying susceptibility to Parvovirus B19, Pseudomonas aeruginosa, and Histoplasma capsulatum infections

Suchergebnisse filtern